DK1732536T3 - Tripolidlactonringderivater som immunomodulatorer og anticancermidler - Google Patents
Tripolidlactonringderivater som immunomodulatorer og anticancermidlerInfo
- Publication number
- DK1732536T3 DK1732536T3 DK05724487.3T DK05724487T DK1732536T3 DK 1732536 T3 DK1732536 T3 DK 1732536T3 DK 05724487 T DK05724487 T DK 05724487T DK 1732536 T3 DK1732536 T3 DK 1732536T3
- Authority
- DK
- Denmark
- Prior art keywords
- tripolid
- anticancers
- immunomodulators
- ring derivatives
- lacton
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 title 1
- 229940121354 immunomodulator Drugs 0.000 title 1
- DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical compound O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 238000011319 anticancer therapy Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002650 immunosuppressive therapy Methods 0.000 abstract 1
- 150000002596 lactones Chemical group 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- YKUJZZHGTWVWHA-UHFFFAOYSA-N triptolide Natural products COC12CC3OC3(C(C)C)C(O)C14OC4CC5C6=C(CCC25C)C(=O)OC6 YKUJZZHGTWVWHA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54976904P | 2004-03-02 | 2004-03-02 | |
| PCT/US2005/006952 WO2005084365A2 (en) | 2004-03-02 | 2005-03-02 | Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1732536T3 true DK1732536T3 (da) | 2012-06-25 |
Family
ID=34919536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05724487.3T DK1732536T3 (da) | 2004-03-02 | 2005-03-02 | Tripolidlactonringderivater som immunomodulatorer og anticancermidler |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7863464B2 (enExample) |
| EP (1) | EP1732536B1 (enExample) |
| JP (1) | JP5057966B2 (enExample) |
| CN (1) | CN100558354C (enExample) |
| AT (1) | ATE554758T1 (enExample) |
| AU (1) | AU2005218610B2 (enExample) |
| CA (1) | CA2557260C (enExample) |
| DK (1) | DK1732536T3 (enExample) |
| ES (1) | ES2385716T3 (enExample) |
| WO (1) | WO2005084365A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003101951A2 (en) * | 2002-05-31 | 2003-12-11 | Pharmagenesis, Inc. | Triptolide derivatives for modulation of apoptosis and immunosuppression |
| US7820834B2 (en) * | 2003-12-24 | 2010-10-26 | Pharmagenesis, Inc. | Triptolide 5,6-derivatives as immunomodulators and anticancer agents |
| WO2005077008A2 (en) * | 2004-02-09 | 2005-08-25 | Pharmagenesis, Inc. | Methods for isolation of triptolide compounds from tripterygium wilfordii |
| ATE554758T1 (de) * | 2004-03-02 | 2012-05-15 | Pharmagenesis Inc | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
| WO2006044496A2 (en) | 2004-10-13 | 2006-04-27 | Pharmagenesis, Inc. | Identification and screening of triptolide target molecules |
| US8268882B2 (en) | 2009-02-05 | 2012-09-18 | Pharmagenesis, Inc. | Triptolide C-ring derivatives as anticancer agents and immune modulators |
| US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
| MY160392A (en) | 2009-05-07 | 2017-03-15 | Univ Minnesota | Triptolide prodrugs |
| US20160038454A1 (en) * | 2013-03-15 | 2016-02-11 | Pharmagenesis, Inc. | Intravenous formulations of triptolide compounds as immunomodulators and anticancer agents |
| WO2015127011A1 (en) | 2014-02-21 | 2015-08-27 | Institute Of Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | C-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition |
| WO2016181312A1 (en) * | 2015-05-11 | 2016-11-17 | Versitech Limited | Polycyclic epoxides and compositions thereof with anti-cancer activities |
| CN107663225A (zh) * | 2016-07-29 | 2018-02-06 | 欣凯医药化工中间体（上海）有限公司 | 一种氟代雷公藤内酯醇内酯环衍生物 |
| CN106749496A (zh) * | 2016-12-05 | 2017-05-31 | 张奇军 | 新型雷公藤甲素衍生物、及其制备和用途 |
| CN108530511B (zh) * | 2017-03-02 | 2021-06-22 | 欣凯医药化工中间体（上海）有限公司 | 一种c19-酰基化雷公藤甲素衍生物 |
| CN108530510A (zh) * | 2017-03-02 | 2018-09-14 | 欣凯医药化工中间体（上海）有限公司 | 一种c19-酰基化雷公藤甲素的制备方法 |
| WO2018222351A1 (en) * | 2017-05-27 | 2018-12-06 | Pharmagenesis, Inc. | Triptolide lactone derivatives as immunomodulators and anticancer agents |
| CN109942665B (zh) * | 2018-04-02 | 2021-04-06 | 欣凯医药化工中间体（上海）有限公司 | 雷公藤内酯醇衍生物及其制备方法和应用 |
| CN110551172B (zh) * | 2018-05-31 | 2021-08-27 | 欣凯医药化工中间体（上海）有限公司 | 一种c-19位双键化雷公藤内酯醇衍生物的合成方法 |
| CN110551171B (zh) * | 2018-05-31 | 2021-07-27 | 欣凯医药化工中间体（上海）有限公司 | 一种雷公藤内酯醇衍生物的制备方法 |
| CN110551170B (zh) * | 2018-05-31 | 2022-04-22 | 欣凯医药化工中间体（上海）有限公司 | 一种c-19位单酰基化雷公藤内酯醇衍生物的合成方法 |
| CN111909119B (zh) * | 2020-08-25 | 2023-06-16 | 上海诗丹德标准技术服务有限公司 | 雷公藤来源化合物及其应用和制备方法、药物组合物、杀虫剂 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005108A (en) * | 1973-04-03 | 1977-01-25 | Research Corporation | Novel anti-leukemic diterpenoid triepoxides |
| CA1310009C (en) | 1984-03-28 | 1992-11-10 | John Mark Braughler | Ester prodrugs of steroids |
| CN1027371C (zh) | 1989-09-08 | 1995-01-11 | 中国医学科学院皮肤病研究所 | 二萜内酯化合物的合成方法 |
| US5430054A (en) | 1989-12-22 | 1995-07-04 | Jiangsu Family Planning Institute | Preparation methods of diterpene lactone compounds and application of the same to antifertility |
| CN1052859A (zh) | 1989-12-22 | 1991-07-10 | 中国医学科学院皮肤病研究所 | 17-羟基雷藤内酯醇及类似物的结构与制备方法 |
| EP0472733B1 (en) | 1990-03-06 | 1994-12-28 | Otsuka Pharmaceutical Co., Ltd. | Phenanthrene derivative |
| US5580562A (en) | 1990-03-14 | 1996-12-03 | Board Of Regents The University Of Texas System | Preparations and uses thereof for immunosuppression |
| WO1991013627A1 (en) | 1990-03-14 | 1991-09-19 | The Board Of Regents, The University Of Texas System | Tripterygium wilfordii hook f extracts and components thereof for immunosuppression |
| US5843452A (en) | 1992-11-09 | 1998-12-01 | Pharmagenesis, Inc. | Immunotherapy composition and method |
| US5468772A (en) | 1993-03-10 | 1995-11-21 | Pharmagenesis, Inc. | Tripterinin compound and method |
| WO1994026265A1 (en) | 1993-05-06 | 1994-11-24 | Pharmagenesis, Inc. | 16-hydroxytriptolide composition and method for immunotherapy |
| US5759550A (en) | 1993-05-06 | 1998-06-02 | Pharmagenesis, Inc. | Method for suppressing xenograft rejection |
| US5919816A (en) | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| US5648376A (en) | 1995-01-19 | 1997-07-15 | Pharmagenesis, Inc. | Immunosuppressant diterpene compound |
| US5663335A (en) | 1996-03-01 | 1997-09-02 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
| US5994064A (en) | 1996-04-24 | 1999-11-30 | Identigene, Inc. | Simple and complex tandem repeats with DNA typing method |
| US6103875A (en) | 1996-11-26 | 2000-08-15 | Pharmagenesis, Inc. | Antifungal compounds from pseudomonas viridiflava |
| US5962516A (en) | 1997-02-28 | 1999-10-05 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
| US5972998A (en) | 1997-05-23 | 1999-10-26 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
| CA2288327A1 (en) | 1997-05-23 | 1998-11-26 | Hoechst Marion Roussel, Inc. | Novel triptolide derivatives useful in the treatment of autoimmune diseases |
| US6004999A (en) | 1997-05-23 | 1999-12-21 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
| ES2178207T3 (es) | 1997-05-23 | 2002-12-16 | Aventis Pharma Inc | Nuevos derivados de triptolida utiles en el tratamiento de enfermedades autoinmunes. |
| US6011042A (en) | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
| US6548537B1 (en) | 1998-09-02 | 2003-04-15 | Pharmagenesis, Inc. | Triptolide prodrugs having high aqueous solubility |
| CN1316997A (zh) | 1998-09-02 | 2001-10-10 | 法玛吉尼西斯公司 | 具有高水溶性的雷公藤内酯前药 |
| US6329148B1 (en) | 1999-02-16 | 2001-12-11 | The Board Of Trustees Of The Leland Stanford University | Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells |
| WO2000063212A1 (en) | 1999-04-16 | 2000-10-26 | Chengdu Diao Pharmaceutical Group Company Limited | Derivatives of triptolide, and preparation and uses thereof |
| US6294546B1 (en) | 1999-08-30 | 2001-09-25 | The Broad Of Trustees Of The Leland Stanford Junior University | Uses of diterpenoid triepoxides as an anti-proliferative agent |
| CN1317248A (zh) | 2000-04-13 | 2001-10-17 | 福建省医学科学研究所 | 紫雷藤杀虫剂及其制备方法 |
| US20020077350A1 (en) | 2000-08-01 | 2002-06-20 | Ashni Naturaceuticals, Inc. | Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 |
| WO2002017931A1 (fr) | 2000-09-01 | 2002-03-07 | Xiaomin Wang | Utilisation d'un ou de plusieurs extraits de tripterygium wilfordii hook.f pour la preparation de medicaments destines a prevenir et a traiter des troubles du systeme nerveux |
| ATE334986T1 (de) | 2000-10-02 | 2006-08-15 | Univ Emory | Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen |
| US6620843B2 (en) | 2001-01-19 | 2003-09-16 | Pharmagenesis | Anticancer treatment using triptolide prodrugs |
| WO2002074759A1 (en) | 2001-03-15 | 2002-09-26 | Pharmagenesis, Inc. | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent |
| WO2003101951A2 (en) | 2002-05-31 | 2003-12-11 | Pharmagenesis, Inc. | Triptolide derivatives for modulation of apoptosis and immunosuppression |
| US20040018260A1 (en) | 2002-06-19 | 2004-01-29 | Novemed Group Limited | Novel botanical extract of Tripterygium Wilfordii Hook F. |
| EP1581208A1 (en) | 2002-12-17 | 2005-10-05 | Pharmagenesis, Inc. | Triptolide derivatives as immunomodulator and anticancer agents |
| US6943259B2 (en) | 2003-02-25 | 2005-09-13 | Pharmagenesis, Inc. | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| WO2005020887A2 (en) * | 2003-06-27 | 2005-03-10 | Pharmagenesis, Inc. | Method for treatment of severe acute respiratory syndrome |
| US7820834B2 (en) | 2003-12-24 | 2010-10-26 | Pharmagenesis, Inc. | Triptolide 5,6-derivatives as immunomodulators and anticancer agents |
| WO2005077008A2 (en) | 2004-02-09 | 2005-08-25 | Pharmagenesis, Inc. | Methods for isolation of triptolide compounds from tripterygium wilfordii |
| ATE554758T1 (de) | 2004-03-02 | 2012-05-15 | Pharmagenesis Inc | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
| US20070244080A1 (en) | 2004-06-25 | 2007-10-18 | Pharmagenesis, Inc. | Method for Treatment of Inflammatory Disorders Using Triptolide Compounds |
-
2005
- 2005-03-02 AT AT05724487T patent/ATE554758T1/de active
- 2005-03-02 CN CNB2005800068751A patent/CN100558354C/zh not_active Expired - Lifetime
- 2005-03-02 WO PCT/US2005/006952 patent/WO2005084365A2/en not_active Ceased
- 2005-03-02 EP EP05724487A patent/EP1732536B1/en not_active Expired - Lifetime
- 2005-03-02 JP JP2007501990A patent/JP5057966B2/ja not_active Expired - Fee Related
- 2005-03-02 CA CA2557260A patent/CA2557260C/en not_active Expired - Fee Related
- 2005-03-02 US US10/591,358 patent/US7863464B2/en not_active Expired - Fee Related
- 2005-03-02 AU AU2005218610A patent/AU2005218610B2/en not_active Ceased
- 2005-03-02 DK DK05724487.3T patent/DK1732536T3/da active
- 2005-03-02 ES ES05724487T patent/ES2385716T3/es not_active Expired - Lifetime
-
2010
- 2010-09-02 US US12/874,434 patent/US8426616B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2557260A1 (en) | 2005-09-15 |
| US20100331554A1 (en) | 2010-12-30 |
| AU2005218610B2 (en) | 2011-08-18 |
| EP1732536B1 (en) | 2012-04-25 |
| CN100558354C (zh) | 2009-11-11 |
| US8426616B2 (en) | 2013-04-23 |
| WO2005084365A3 (en) | 2005-11-10 |
| JP2007526331A (ja) | 2007-09-13 |
| WO2005084365A2 (en) | 2005-09-15 |
| US7863464B2 (en) | 2011-01-04 |
| EP1732536A2 (en) | 2006-12-20 |
| ES2385716T3 (es) | 2012-07-30 |
| EP1732536A4 (en) | 2009-06-10 |
| JP5057966B2 (ja) | 2012-10-24 |
| CA2557260C (en) | 2013-02-12 |
| CN1925852A (zh) | 2007-03-07 |
| AU2005218610A1 (en) | 2005-09-15 |
| US20080287530A1 (en) | 2008-11-20 |
| ATE554758T1 (de) | 2012-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1732536T3 (da) | Tripolidlactonringderivater som immunomodulatorer og anticancermidler | |
| NO2020031I1 (no) | kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat | |
| WO2006038923A3 (en) | Aryl substituted imidazonaphthyridines | |
| NO20082305L (no) | Mikrobiologisk stabilisert ol | |
| ATE455452T1 (de) | Plasmabrennerkopf, plasmabrennerschaft und plasmabrenner | |
| NO20073065L (no) | Injiserbare nanopartikulaere olanzapinformuleringer | |
| NO20043101L (no) | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet | |
| CL2011002739A1 (es) | Compuestos derivados de 3-(1h-pirrolo[2,3-b]piridina-3-carbonil)-bencenosulfonamida; composicion farmaceutica que los comprende; kit; y su uso como inhibidores de raf para el tratamiento de una enfermedad o condicion seleccionada de melanoma, glioma, glioblastoma multiforme, cancer colorrectal, cancer de pulmon, entre otras. | |
| NO20054682L (no) | Sikker transdermal doseringsform | |
| NO20072179L (no) | Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer | |
| NO20075148L (no) | Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner | |
| UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
| DK1802625T3 (da) | Disubstituerede pyrazolobenzodiazepiner der er nyttige som inhibitorer af CDK2 og angiogenese og til behandling af bryst-, tyktarms-, lunge- og prostatacancer | |
| EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
| NO20064555L (no) | HIV-integraseinhibitorer. | |
| NO20070608L (no) | Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast | |
| LTC2805723I2 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
| UA97369C2 (ru) | Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе | |
| WO2008051197A3 (en) | Small-molecule botulinum toxin inhibitors | |
| WO2005074598A3 (en) | Nitroxyl progenitor compounds and methods of use | |
| UY29213A1 (es) | Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación | |
| NO20044526L (no) | Hemisterlinderivater og anvendelser derav | |
| MX2007008723A (es) | Polipeptidos de yersinia spp y metodos de uso. | |
| NO20050019L (no) | Polytylenglykolaldehyd-derivater | |
| DK1553942T3 (da) | Farmaceutisk præparat, der kombinerer tenatoprazol og et antiinflammatorisk middel |